CRMP2 expression and activity were examined in pairwise in situ SW480 (Dukes’ type B) and metastatic SW620 (Dukes’ type C) CRC cell lines to elucidate the roles of CRMP2 in CRC cells with distinctive malignant potential under differential glucose-containing environments. Here, DPYSL2 is linked to colorectal carcinoma.